

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.46389981 |
| 2 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.34217379 |
| 3 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.24714222 |
| 4 | vocalization behavior (GO:0071625) | 4.16791016 |
| 5 | locomotory exploration behavior (GO:0035641) | 4.12514428 |
| 6 | synaptic vesicle maturation (GO:0016188) | 4.02875005 |
| 7 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.98340230 |
| 8 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.92211719 |
| 9 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.86299047 |
| 10 | COPI coating of Golgi vesicle (GO:0048205) | 3.84573119 |
| 11 | Golgi transport vesicle coating (GO:0048200) | 3.84573119 |
| 12 | cell communication by electrical coupling (GO:0010644) | 3.82953696 |
| 13 | plasma membrane repair (GO:0001778) | 3.76875683 |
| 14 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.74412114 |
| 15 | regulation of synapse structural plasticity (GO:0051823) | 3.71303883 |
| 16 | detection of calcium ion (GO:0005513) | 3.70774866 |
| 17 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.70382475 |
| 18 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.69800585 |
| 19 | synaptic vesicle exocytosis (GO:0016079) | 3.64768336 |
| 20 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.61599178 |
| 21 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.59151610 |
| 22 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.58486996 |
| 23 | glutamate receptor signaling pathway (GO:0007215) | 3.55797137 |
| 24 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.53523969 |
| 25 | protein retention in ER lumen (GO:0006621) | 3.52764988 |
| 26 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.49744573 |
| 27 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.46221653 |
| 28 | neuronal action potential propagation (GO:0019227) | 3.40587126 |
| 29 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.39130991 |
| 30 | exploration behavior (GO:0035640) | 3.39027442 |
| 31 | activation of protein kinase A activity (GO:0034199) | 3.38208055 |
| 32 | regulation of synaptic vesicle transport (GO:1902803) | 3.37686585 |
| 33 | cellular potassium ion homeostasis (GO:0030007) | 3.35942670 |
| 34 | cell communication involved in cardiac conduction (GO:0086065) | 3.34828767 |
| 35 | protein localization to synapse (GO:0035418) | 3.34447965 |
| 36 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.34031768 |
| 37 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.33116696 |
| 38 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.32842760 |
| 39 | synaptic transmission, glutamatergic (GO:0035249) | 3.29687629 |
| 40 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.28897739 |
| 41 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.27417925 |
| 42 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.16903799 |
| 43 | glutamate secretion (GO:0014047) | 3.16554498 |
| 44 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.16158771 |
| 45 | sodium ion export (GO:0071436) | 3.15013457 |
| 46 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.13618655 |
| 47 | long-term memory (GO:0007616) | 3.13046085 |
| 48 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.11499742 |
| 49 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.11499742 |
| 50 | neuron-neuron synaptic transmission (GO:0007270) | 3.09747030 |
| 51 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.09296047 |
| 52 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.09001145 |
| 53 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.08082686 |
| 54 | skin morphogenesis (GO:0043589) | 3.05712125 |
| 55 | innervation (GO:0060384) | 3.05008436 |
| 56 | desmosome organization (GO:0002934) | 3.04231545 |
| 57 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.03784089 |
| 58 | regulation of synaptic plasticity (GO:0048167) | 3.03620941 |
| 59 | vesicle transport along microtubule (GO:0047496) | 3.03544559 |
| 60 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.02642841 |
| 61 | basement membrane organization (GO:0071711) | 3.00925218 |
| 62 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.00770289 |
| 63 | striatum development (GO:0021756) | 3.00474119 |
| 64 | behavioral defense response (GO:0002209) | 2.99936430 |
| 65 | behavioral fear response (GO:0001662) | 2.99936430 |
| 66 | regulation of postsynaptic membrane potential (GO:0060078) | 2.97063329 |
| 67 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.95139012 |
| 68 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.94207890 |
| 69 | regulation of membrane repolarization (GO:0060306) | 2.94137927 |
| 70 | dendritic spine morphogenesis (GO:0060997) | 2.93579678 |
| 71 | dendritic spine organization (GO:0097061) | 2.91818432 |
| 72 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.91594072 |
| 73 | neuron recognition (GO:0008038) | 2.91165704 |
| 74 | neurotransmitter secretion (GO:0007269) | 2.90111591 |
| 75 | neuron cell-cell adhesion (GO:0007158) | 2.87993123 |
| 76 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.87220217 |
| 77 | fear response (GO:0042596) | 2.87200609 |
| 78 | membrane depolarization during action potential (GO:0086010) | 2.87051178 |
| 79 | long term synaptic depression (GO:0060292) | 2.86894545 |
| 80 | potassium ion import (GO:0010107) | 2.86220585 |
| 81 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.84793985 |
| 82 | long-term synaptic potentiation (GO:0060291) | 2.84646438 |
| 83 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.83995869 |
| 84 | epithelial cell-cell adhesion (GO:0090136) | 2.81902722 |
| 85 | regulation of female receptivity (GO:0045924) | 2.80748260 |
| 86 | regulation of extracellular matrix disassembly (GO:0010715) | 2.80691895 |
| 87 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.80170116 |
| 88 | regulation of vesicle fusion (GO:0031338) | 2.77226458 |
| 89 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.76967473 |
| 90 | neuromuscular process controlling balance (GO:0050885) | 2.76884903 |
| 91 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.76382246 |
| 92 | adherens junction assembly (GO:0034333) | 2.76298884 |
| 93 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.74833859 |
| 94 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.72697986 |
| 95 | neuronal ion channel clustering (GO:0045161) | 2.72662135 |
| 96 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.72588301 |
| 97 | layer formation in cerebral cortex (GO:0021819) | 2.71745122 |
| 98 | apoptotic cell clearance (GO:0043277) | 2.71637330 |
| 99 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.71240826 |
| 100 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.71232789 |
| 101 | positive regulation of membrane potential (GO:0045838) | 2.69750920 |
| 102 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.69265360 |
| 103 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.69265360 |
| 104 | inner ear receptor cell development (GO:0060119) | 2.69115048 |
| 105 | membrane repolarization (GO:0086009) | 2.69100411 |
| 106 | positive regulation of synapse maturation (GO:0090129) | 2.68836847 |
| 107 | cardiac muscle contraction (GO:0060048) | 2.67139830 |
| 108 | positive regulation of vesicle fusion (GO:0031340) | 2.66940335 |
| 109 | axonal fasciculation (GO:0007413) | 2.66933380 |
| 110 | female mating behavior (GO:0060180) | 2.66802749 |
| 111 | regulation of ion transmembrane transporter activity (GO:0032412) | 2.66427984 |
| 112 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.66268675 |
| 113 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.66084535 |
| 114 | proline transport (GO:0015824) | 2.65650590 |
| 115 | relaxation of cardiac muscle (GO:0055119) | 2.64735330 |
| 116 | positive regulation of potassium ion transport (GO:0043268) | 2.63741182 |
| 117 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.58933401 |
| 118 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.55769921 |
| 119 | protein heterotrimerization (GO:0070208) | 2.50775040 |
| 120 | lung epithelium development (GO:0060428) | 2.48004132 |
| 121 | focal adhesion assembly (GO:0048041) | 2.47599610 |
| 122 | cell-substrate adherens junction assembly (GO:0007045) | 2.47599610 |
| 123 | L-serine transport (GO:0015825) | 2.46156884 |
| 124 | cell volume homeostasis (GO:0006884) | 2.44372387 |
| 125 | endocardial cushion development (GO:0003197) | 2.42864796 |
| 126 | endothelial cell morphogenesis (GO:0001886) | 2.42401709 |
| 127 | fatty acid homeostasis (GO:0055089) | 2.41956871 |
| 128 | glomerular basement membrane development (GO:0032836) | 2.40880267 |
| 129 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.40826565 |
| 130 | cell-substrate junction assembly (GO:0007044) | 2.40653943 |
| 131 | endothelial cell chemotaxis (GO:0035767) | 2.38819666 |
| 132 | chondrocyte proliferation (GO:0035988) | 2.38780813 |
| 133 | semaphorin-plexin signaling pathway (GO:0071526) | 2.38173810 |
| 134 | regulation of cholesterol homeostasis (GO:2000188) | 2.36139827 |
| 135 | protein carboxylation (GO:0018214) | 2.35010603 |
| 136 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.35010603 |
| 137 | establishment of apical/basal cell polarity (GO:0035089) | 2.33114605 |
| 138 | cerebellar Purkinje cell layer development (GO:0021680) | 2.28103886 |
| 139 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.28078626 |
| 140 | endocrine hormone secretion (GO:0060986) | 2.27309176 |
| 141 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.26849543 |
| 142 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.23955835 |
| 143 | regulation of cardioblast differentiation (GO:0051890) | 2.23409233 |
| 144 | cellular zinc ion homeostasis (GO:0006882) | 2.22918828 |
| 145 | macroautophagy (GO:0016236) | 2.21841288 |
| 146 | 4-hydroxyproline metabolic process (GO:0019471) | 2.17372064 |
| 147 | COPII vesicle coating (GO:0048208) | 2.16895738 |
| 148 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.13317306 |
| 149 | vesicle coating (GO:0006901) | 2.12378350 |
| 150 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.12230748 |
| 151 | cell-cell junction maintenance (GO:0045217) | 2.12174040 |
| 152 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.10833153 |
| 153 | hemidesmosome assembly (GO:0031581) | 2.10520037 |
| 154 | NADH metabolic process (GO:0006734) | 2.09994220 |
| 155 | barbed-end actin filament capping (GO:0051016) | 2.09800303 |
| 156 | extracellular fibril organization (GO:0043206) | 2.09768266 |
| 157 | atrioventricular valve morphogenesis (GO:0003181) | 2.08468661 |
| 158 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.06941737 |
| 159 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.06690262 |
| 160 | regulation of cholesterol metabolic process (GO:0090181) | 2.05862730 |
| 161 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.05568280 |
| 162 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.05395726 |
| 163 | * activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.03634597 |
| 164 | positive regulation of receptor recycling (GO:0001921) | 2.03535641 |
| 165 | type B pancreatic cell proliferation (GO:0044342) | 2.03391254 |
| 166 | cellular sodium ion homeostasis (GO:0006883) | 2.03384528 |
| 167 | paraxial mesoderm development (GO:0048339) | 2.01856263 |
| 168 | extracellular matrix assembly (GO:0085029) | 2.01836867 |
| 169 | surfactant homeostasis (GO:0043129) | 2.01289323 |
| 170 | cell adhesion mediated by integrin (GO:0033627) | 1.99662573 |
| 171 | low-density lipoprotein particle clearance (GO:0034383) | 1.99650241 |
| 172 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 1.99090697 |
| 173 | regulation of integrin-mediated signaling pathway (GO:2001044) | 1.99010388 |
| 174 | negative regulation of hormone metabolic process (GO:0032351) | 1.97979954 |
| 175 | renal absorption (GO:0070293) | 1.97438112 |
| 176 | embryo implantation (GO:0007566) | 1.97400557 |
| 177 | regulation of establishment of planar polarity (GO:0090175) | 1.97386818 |
| 178 | protein targeting to plasma membrane (GO:0072661) | 1.96942418 |
| 179 | non-canonical Wnt signaling pathway (GO:0035567) | 1.96403105 |
| 180 | regulation of glucocorticoid metabolic process (GO:0031943) | 1.95707624 |
| 181 | regulation of extracellular matrix organization (GO:1903053) | 1.95568019 |
| 182 | endodermal cell differentiation (GO:0035987) | 1.94922509 |
| 183 | glomerular epithelial cell development (GO:0072310) | 1.94466894 |
| 184 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 1.94376621 |
| 185 | L-phenylalanine metabolic process (GO:0006558) | 1.93547805 |
| 186 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 1.93547805 |
| 187 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 1.92739668 |
| 188 | positive regulation of steroid biosynthetic process (GO:0010893) | 1.91912997 |
| 189 | protein localization to endosome (GO:0036010) | 1.91852295 |
| 190 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 1.91193866 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.54550524 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.38718487 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.30342646 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.01417355 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.95776398 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.90462751 |
| 7 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.88740262 |
| 8 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.79957297 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.73716361 |
| 10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.69243688 |
| 11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.63421318 |
| 12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.63045758 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.52565373 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.52565373 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.50376616 |
| 16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.49593291 |
| 17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.46150381 |
| 18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.44129239 |
| 19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.44071514 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.43920754 |
| 21 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.43616424 |
| 22 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.42627756 |
| 23 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.31449952 |
| 24 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.28364131 |
| 25 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.22123816 |
| 26 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.17065358 |
| 27 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.16231750 |
| 28 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.15814591 |
| 29 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.15498190 |
| 30 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.12361579 |
| 31 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.10240025 |
| 32 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.05204147 |
| 33 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.02265793 |
| 34 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.01073480 |
| 35 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.99708819 |
| 36 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.99320067 |
| 37 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.88685418 |
| 38 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.73684485 |
| 39 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.72234297 |
| 40 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.70604207 |
| 41 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.68829942 |
| 42 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.68041959 |
| 43 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.66267391 |
| 44 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.65153111 |
| 45 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.64744589 |
| 46 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.64594286 |
| 47 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.59186727 |
| 48 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.54120293 |
| 49 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.53450240 |
| 50 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.50938338 |
| 51 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.47997634 |
| 52 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.47868662 |
| 53 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.47868662 |
| 54 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.45674566 |
| 55 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.45325570 |
| 56 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.42116879 |
| 57 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.41708034 |
| 58 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.41232846 |
| 59 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.40566678 |
| 60 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.39657995 |
| 61 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.38933796 |
| 62 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.38874271 |
| 63 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.38318427 |
| 64 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.34818085 |
| 65 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32457200 |
| 66 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.31299527 |
| 67 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.30669126 |
| 68 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.30168367 |
| 69 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.29819681 |
| 70 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.29695336 |
| 71 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.29567579 |
| 72 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.28282371 |
| 73 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.27550812 |
| 74 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.27430848 |
| 75 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.26434445 |
| 76 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.26417135 |
| 77 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.25862504 |
| 78 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.25765653 |
| 79 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25689725 |
| 80 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.25073171 |
| 81 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.23947734 |
| 82 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.22619627 |
| 83 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.22591732 |
| 84 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.21835598 |
| 85 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21578587 |
| 86 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.20310332 |
| 87 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.20273833 |
| 88 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.20118149 |
| 89 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.19284076 |
| 90 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.18912897 |
| 91 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.18131246 |
| 92 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.18103525 |
| 93 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.18061820 |
| 94 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.17553085 |
| 95 | * AR_19668381_ChIP-Seq_PC3_Human | 1.17009724 |
| 96 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16726846 |
| 97 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.16549499 |
| 98 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.16145081 |
| 99 | KDM2B_26808549_Chip-Seq_K562_Human | 1.15981029 |
| 100 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.15037684 |
| 101 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.14814186 |
| 102 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.14759172 |
| 103 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.14680768 |
| 104 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.12646871 |
| 105 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.12639038 |
| 106 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12153761 |
| 107 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.11997177 |
| 108 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.11749576 |
| 109 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.11301399 |
| 110 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.10619645 |
| 111 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.10098735 |
| 112 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09842035 |
| 113 | STAT3_23295773_ChIP-Seq_U87_Human | 1.09712984 |
| 114 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.09114555 |
| 115 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.08959086 |
| 116 | AR_25329375_ChIP-Seq_VCAP_Human | 1.08463356 |
| 117 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.08088485 |
| 118 | ATF3_27146783_Chip-Seq_COLON_Human | 1.07229606 |
| 119 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.07026095 |
| 120 | P300_19829295_ChIP-Seq_ESCs_Human | 1.06756735 |
| 121 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.06654672 |
| 122 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.06588729 |
| 123 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.06215874 |
| 124 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05775113 |
| 125 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.04546210 |
| 126 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.04426749 |
| 127 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04300988 |
| 128 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.03719739 |
| 129 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.02754916 |
| 130 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02446549 |
| 131 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.02114386 |
| 132 | TP53_16413492_ChIP-PET_HCT116_Human | 1.01897448 |
| 133 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.01870697 |
| 134 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01404530 |
| 135 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.01132071 |
| 136 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.01043421 |
| 137 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99362562 |
| 138 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.99234211 |
| 139 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98440183 |
| 140 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98315689 |
| 141 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97067298 |
| 142 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95919132 |
| 143 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.95561675 |
| 144 | TCF4_23295773_ChIP-Seq_U87_Human | 0.94527101 |
| 145 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.93784534 |
| 146 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.93004559 |
| 147 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.92880784 |
| 148 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.91200673 |
| 149 | VDR_22108803_ChIP-Seq_LS180_Human | 0.90163021 |
| 150 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.90080422 |
| 151 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.89768065 |
| 152 | RXR_22108803_ChIP-Seq_LS180_Human | 0.89521218 |
| 153 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88910919 |
| 154 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.88542501 |
| 155 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.87542854 |
| 156 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.87539760 |
| 157 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.85934622 |
| 158 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85421821 |
| 159 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.84518774 |
| 160 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.84489076 |
| 161 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.84256389 |
| 162 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.83306027 |
| 163 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.82870435 |
| 164 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.81519159 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.60169015 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 4.16186395 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 4.01651456 |
| 4 | MP0003880_abnormal_central_pattern | 3.96092411 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 3.42457589 |
| 6 | MP0004272_abnormal_basement_membrane | 3.20453945 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 3.07210806 |
| 8 | MP0000751_myopathy | 2.86609730 |
| 9 | MP0002822_catalepsy | 2.85450403 |
| 10 | * MP0004270_analgesia | 2.82526761 |
| 11 | * MP0002063_abnormal_learning/memory/cond | 2.75759362 |
| 12 | MP0009780_abnormal_chondrocyte_physiolo | 2.73945471 |
| 13 | * MP0009745_abnormal_behavioral_response | 2.61286266 |
| 14 | MP0002909_abnormal_adrenal_gland | 2.53922148 |
| 15 | MP0010368_abnormal_lymphatic_system | 2.52038110 |
| 16 | MP0003566_abnormal_cell_adhesion | 2.48584175 |
| 17 | MP0005257_abnormal_intraocular_pressure | 2.34402809 |
| 18 | MP0002064_seizures | 2.32800526 |
| 19 | MP0001958_emphysema | 2.24661906 |
| 20 | MP0001968_abnormal_touch/_nociception | 2.24115430 |
| 21 | MP0004145_abnormal_muscle_electrophysio | 2.20574034 |
| 22 | MP0010234_abnormal_vibrissa_follicle | 2.18891749 |
| 23 | * MP0002572_abnormal_emotion/affect_behav | 2.17780881 |
| 24 | MP0005623_abnormal_meninges_morphology | 2.11690088 |
| 25 | MP0003279_aneurysm | 2.11316367 |
| 26 | MP0004215_abnormal_myocardial_fiber | 2.10526328 |
| 27 | MP0003646_muscle_fatigue | 2.08664839 |
| 28 | MP0000013_abnormal_adipose_tissue | 2.01073183 |
| 29 | MP0002272_abnormal_nervous_system | 2.00590407 |
| 30 | MP0001501_abnormal_sleep_pattern | 1.98095101 |
| 31 | MP0004036_abnormal_muscle_relaxation | 1.97385100 |
| 32 | MP0002736_abnormal_nociception_after | 1.96187618 |
| 33 | MP0000749_muscle_degeneration | 1.94241443 |
| 34 | MP0004084_abnormal_cardiac_muscle | 1.89976307 |
| 35 | MP0002734_abnormal_mechanical_nocicepti | 1.88178955 |
| 36 | MP0003329_amyloid_beta_deposits | 1.85685733 |
| 37 | MP0010030_abnormal_orbit_morphology | 1.82332816 |
| 38 | MP0005503_abnormal_tendon_morphology | 1.81007289 |
| 39 | MP0002295_abnormal_pulmonary_circulatio | 1.79163829 |
| 40 | MP0003283_abnormal_digestive_organ | 1.75627181 |
| 41 | MP0001440_abnormal_grooming_behavior | 1.73740238 |
| 42 | MP0005409_darkened_coat_color | 1.72334794 |
| 43 | MP0005670_abnormal_white_adipose | 1.71125408 |
| 44 | MP0001486_abnormal_startle_reflex | 1.70596423 |
| 45 | MP0005058_abnormal_lysosome_morphology | 1.66832414 |
| 46 | MP0002733_abnormal_thermal_nociception | 1.65962771 |
| 47 | MP0009046_muscle_twitch | 1.63495563 |
| 48 | MP0004858_abnormal_nervous_system | 1.62737515 |
| 49 | MP0005275_abnormal_skin_tensile | 1.62278450 |
| 50 | MP0002735_abnormal_chemical_nociception | 1.61360961 |
| 51 | MP0001970_abnormal_pain_threshold | 1.57277688 |
| 52 | MP0000566_synostosis | 1.56288196 |
| 53 | MP0009384_cardiac_valve_regurgitation | 1.51470241 |
| 54 | MP0010386_abnormal_urinary_bladder | 1.48720089 |
| 55 | MP0005330_cardiomyopathy | 1.48268501 |
| 56 | MP0005646_abnormal_pituitary_gland | 1.47765078 |
| 57 | MP0005620_abnormal_muscle_contractility | 1.47753727 |
| 58 | MP0004484_altered_response_of | 1.46139769 |
| 59 | MP0002896_abnormal_bone_mineralization | 1.45089493 |
| 60 | MP0001299_abnormal_eye_distance/ | 1.44652963 |
| 61 | MP0004085_abnormal_heartbeat | 1.43509624 |
| 62 | MP0000747_muscle_weakness | 1.42713801 |
| 63 | MP0004043_abnormal_pH_regulation | 1.38903871 |
| 64 | MP0002067_abnormal_sensory_capabilities | 1.38520444 |
| 65 | MP0002234_abnormal_pharynx_morphology | 1.36079472 |
| 66 | MP0008569_lethality_at_weaning | 1.34950211 |
| 67 | MP0004233_abnormal_muscle_weight | 1.34771311 |
| 68 | MP0004087_abnormal_muscle_fiber | 1.34751866 |
| 69 | MP0003123_paternal_imprinting | 1.34531430 |
| 70 | MP0001849_ear_inflammation | 1.34516965 |
| 71 | MP0003137_abnormal_impulse_conducting | 1.34468621 |
| 72 | MP0000767_abnormal_smooth_muscle | 1.32218623 |
| 73 | MP0003091_abnormal_cell_migration | 1.32018438 |
| 74 | MP0004510_myositis | 1.31198792 |
| 75 | MP0000462_abnormal_digestive_system | 1.31158189 |
| 76 | MP0005375_adipose_tissue_phenotype | 1.31067290 |
| 77 | MP0002972_abnormal_cardiac_muscle | 1.30206610 |
| 78 | MP0005423_abnormal_somatic_nervous | 1.28490998 |
| 79 | MP0002269_muscular_atrophy | 1.27977037 |
| 80 | MP0002106_abnormal_muscle_physiology | 1.27939082 |
| 81 | MP0002184_abnormal_innervation | 1.27213082 |
| 82 | MP0008961_abnormal_basal_metabolism | 1.25007951 |
| 83 | MP0003879_abnormal_hair_cell | 1.23586898 |
| 84 | MP0004811_abnormal_neuron_physiology | 1.22706269 |
| 85 | MP0002060_abnormal_skin_morphology | 1.21105908 |
| 86 | MP0004130_abnormal_muscle_cell | 1.19862314 |
| 87 | MP0009840_abnormal_foam_cell | 1.18677997 |
| 88 | MP0002557_abnormal_social/conspecific_i | 1.17700313 |
| 89 | MP0003941_abnormal_skin_development | 1.17317809 |
| 90 | MP0003942_abnormal_urinary_system | 1.17060615 |
| 91 | MP0005508_abnormal_skeleton_morphology | 1.17026901 |
| 92 | * MP0004924_abnormal_behavior | 1.15588314 |
| 93 | * MP0005386_behavior/neurological_phenoty | 1.15588314 |
| 94 | MP0000759_abnormal_skeletal_muscle | 1.14821707 |
| 95 | MP0001502_abnormal_circadian_rhythm | 1.12903857 |
| 96 | MP0000955_abnormal_spinal_cord | 1.12604703 |
| 97 | MP0000534_abnormal_ureter_morphology | 1.11636592 |
| 98 | MP0003633_abnormal_nervous_system | 1.10662421 |
| 99 | MP0005369_muscle_phenotype | 1.10082161 |
| 100 | MP0001984_abnormal_olfaction | 1.09831890 |
| 101 | MP0002089_abnormal_postnatal_growth/wei | 1.09271641 |
| 102 | MP0006276_abnormal_autonomic_nervous | 1.09064592 |
| 103 | * MP0002066_abnormal_motor_capabilities/c | 1.08354551 |
| 104 | MP0005535_abnormal_body_temperature | 1.07768953 |
| 105 | MP0002108_abnormal_muscle_morphology | 1.07262986 |
| 106 | MP0002254_reproductive_system_inflammat | 1.04312960 |
| 107 | MP0004782_abnormal_surfactant_physiolog | 1.00223607 |
| 108 | MP0002882_abnormal_neuron_morphology | 0.99439756 |
| 109 | MP0000778_abnormal_nervous_system | 0.98462007 |
| 110 | MP0005023_abnormal_wound_healing | 0.98143377 |
| 111 | MP0002877_abnormal_melanocyte_morpholog | 0.97810239 |
| 112 | MP0003172_abnormal_lysosome_physiology | 0.97725902 |
| 113 | MP0002249_abnormal_larynx_morphology | 0.96749184 |
| 114 | MP0010329_abnormal_lipoprotein_level | 0.94802112 |
| 115 | MP0000762_abnormal_tongue_morphology | 0.93948374 |
| 116 | MP0000750_abnormal_muscle_regeneration | 0.92414218 |
| 117 | MP0006138_congestive_heart_failure | 0.91976281 |
| 118 | MP0001765_abnormal_ion_homeostasis | 0.90831463 |
| 119 | MP0000003_abnormal_adipose_tissue | 0.90821503 |
| 120 | * MP0002693_abnormal_pancreas_physiology | 0.88186561 |
| 121 | MP0003122_maternal_imprinting | 0.87263222 |
| 122 | MP0004885_abnormal_endolymph | 0.85871987 |
| 123 | MP0003950_abnormal_plasma_membrane | 0.85694061 |
| 124 | MP0005666_abnormal_adipose_tissue | 0.85547411 |
| 125 | MP0005595_abnormal_vascular_smooth | 0.85514581 |
| 126 | MP0001661_extended_life_span | 0.85243047 |
| 127 | MP0005645_abnormal_hypothalamus_physiol | 0.83415780 |
| 128 | MP0003075_altered_response_to | 0.82599793 |
| 129 | MP0003787_abnormal_imprinting | 0.82448534 |
| 130 | MP0001879_abnormal_lymphatic_vessel | 0.80588318 |
| 131 | MP0003631_nervous_system_phenotype | 0.80584358 |
| 132 | * MP0002078_abnormal_glucose_homeostasis | 0.80462567 |
| 133 | MP0000678_abnormal_parathyroid_gland | 0.80374168 |
| 134 | MP0002796_impaired_skin_barrier | 0.79972453 |
| 135 | MP0008874_decreased_physiological_sensi | 0.78044992 |
| 136 | MP0005385_cardiovascular_system_phenoty | 0.76997182 |
| 137 | MP0001544_abnormal_cardiovascular_syste | 0.76997182 |
| 138 | MP0002229_neurodegeneration | 0.76781786 |
| 139 | MP0001542_abnormal_bone_strength | 0.76679796 |
| 140 | * MP0002069_abnormal_eating/drinking_beha | 0.76126930 |
| 141 | MP0005165_increased_susceptibility_to | 0.73590023 |
| 142 | MP0000604_amyloidosis | 0.73418693 |
| 143 | MP0002971_abnormal_brown_adipose | 0.73218173 |
| 144 | MP0003115_abnormal_respiratory_system | 0.71717901 |
| 145 | MP0003634_abnormal_glial_cell | 0.71439374 |
| 146 | * MP0001944_abnormal_pancreas_morphology | 0.71089330 |
| 147 | MP0001756_abnormal_urination | 0.70181416 |
| 148 | MP0006072_abnormal_retinal_apoptosis | 0.69949246 |
| 149 | MP0001905_abnormal_dopamine_level | 0.69899558 |
| 150 | MP0005187_abnormal_penis_morphology | 0.69847707 |
| 151 | MP0002152_abnormal_brain_morphology | 0.67848894 |
| 152 | MP0002876_abnormal_thyroid_physiology | 0.67762133 |
| 153 | MP0005076_abnormal_cell_differentiation | 0.67138604 |
| 154 | MP0003453_abnormal_keratinocyte_physiol | 0.66656909 |
| 155 | MP0008775_abnormal_heart_ventricle | 0.65641543 |
| 156 | MP0010630_abnormal_cardiac_muscle | 0.64997916 |
| 157 | MP0004133_heterotaxia | 0.64129690 |
| 158 | MP0000163_abnormal_cartilage_morphology | 0.63828963 |
| 159 | MP0009672_abnormal_birth_weight | 0.63788639 |
| 160 | MP0004019_abnormal_vitamin_homeostasis | 0.63372804 |
| 161 | MP0000733_abnormal_muscle_development | 0.60900099 |
| 162 | MP0000467_abnormal_esophagus_morphology | 0.59624080 |
| 163 | MP0001614_abnormal_blood_vessel | 0.59568790 |
| 164 | MP0001915_intracranial_hemorrhage | 0.59039636 |
| 165 | MP0002116_abnormal_craniofacial_bone | 0.58814463 |
| 166 | MP0002168_other_aberrant_phenotype | 0.58621504 |
| 167 | MP0001243_abnormal_dermal_layer | 0.58615928 |
| 168 | MP0002128_abnormal_blood_circulation | 0.58060426 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.84985267 |
| 2 | Myokymia (HP:0002411) | 5.00819412 |
| 3 | Premature rupture of membranes (HP:0001788) | 4.95329694 |
| 4 | Protrusio acetabuli (HP:0003179) | 4.92068858 |
| 5 | Visual hallucinations (HP:0002367) | 4.32432671 |
| 6 | Sudden death (HP:0001699) | 4.27477027 |
| 7 | Focal seizures (HP:0007359) | 4.14417813 |
| 8 | Exercise-induced myalgia (HP:0003738) | 3.86188359 |
| 9 | Calf muscle hypertrophy (HP:0008981) | 3.83954287 |
| 10 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.61705718 |
| 11 | Epileptic encephalopathy (HP:0200134) | 3.26855465 |
| 12 | Abnormality of the calf musculature (HP:0001430) | 3.25555669 |
| 13 | Vertebral compression fractures (HP:0002953) | 3.22856471 |
| 14 | Absence seizures (HP:0002121) | 3.18465905 |
| 15 | Syncope (HP:0001279) | 3.17222503 |
| 16 | Bundle branch block (HP:0011710) | 3.15845181 |
| 17 | Atonic seizures (HP:0010819) | 3.12151188 |
| 18 | Cervical subluxation (HP:0003308) | 3.09900368 |
| 19 | Generalized tonic-clonic seizures (HP:0002069) | 3.06948543 |
| 20 | Prolonged QT interval (HP:0001657) | 3.04102154 |
| 21 | Vascular tortuosity (HP:0004948) | 3.03993580 |
| 22 | Ventricular fibrillation (HP:0001663) | 2.97193835 |
| 23 | Exercise-induced muscle cramps (HP:0003710) | 2.96879037 |
| 24 | Supranuclear gaze palsy (HP:0000605) | 2.95964377 |
| 25 | Cerebral inclusion bodies (HP:0100314) | 2.95892659 |
| 26 | Dialeptic seizures (HP:0011146) | 2.93715591 |
| 27 | Primary atrial arrhythmia (HP:0001692) | 2.88270018 |
| 28 | Arterial tortuosity (HP:0005116) | 2.86918388 |
| 29 | Abnormality of dentin (HP:0010299) | 2.85267713 |
| 30 | Hyperventilation (HP:0002883) | 2.84895057 |
| 31 | Atrial fibrillation (HP:0005110) | 2.82306585 |
| 32 | Depression (HP:0000716) | 2.78523717 |
| 33 | Mitral stenosis (HP:0001718) | 2.78326549 |
| 34 | Shallow orbits (HP:0000586) | 2.77243506 |
| 35 | Distal upper limb amyotrophy (HP:0007149) | 2.74066654 |
| 36 | Upper limb amyotrophy (HP:0009129) | 2.74066654 |
| 37 | Cerebral aneurysm (HP:0004944) | 2.73840596 |
| 38 | Spinal rigidity (HP:0003306) | 2.73724354 |
| 39 | Ankle contracture (HP:0006466) | 2.73371473 |
| 40 | Supraventricular tachycardia (HP:0004755) | 2.71801692 |
| 41 | Abnormal EKG (HP:0003115) | 2.70802642 |
| 42 | Cardiovascular calcification (HP:0011915) | 2.69615200 |
| 43 | Distal lower limb muscle weakness (HP:0009053) | 2.69428080 |
| 44 | Hyporeflexia of lower limbs (HP:0002600) | 2.68764786 |
| 45 | EMG: myopathic abnormalities (HP:0003458) | 2.68174301 |
| 46 | Neurofibrillary tangles (HP:0002185) | 2.66354244 |
| 47 | Supraventricular arrhythmia (HP:0005115) | 2.65812251 |
| 48 | Vascular calcification (HP:0004934) | 2.64460851 |
| 49 | Action tremor (HP:0002345) | 2.63923659 |
| 50 | Myotonia (HP:0002486) | 2.57262581 |
| 51 | Muscle fiber splitting (HP:0003555) | 2.56713933 |
| 52 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.56214921 |
| 53 | Short nail (HP:0001799) | 2.56048148 |
| 54 | Febrile seizures (HP:0002373) | 2.56036533 |
| 55 | * Anxiety (HP:0000739) | 2.54327106 |
| 56 | Epileptiform EEG discharges (HP:0011182) | 2.53999452 |
| 57 | Poor eye contact (HP:0000817) | 2.52268220 |
| 58 | Amblyopia (HP:0000646) | 2.49482991 |
| 59 | Aortic dissection (HP:0002647) | 2.48783832 |
| 60 | Broad metatarsal (HP:0001783) | 2.46095762 |
| 61 | Difficulty running (HP:0009046) | 2.45977987 |
| 62 | Abnormal social behavior (HP:0012433) | 2.45155591 |
| 63 | Impaired social interactions (HP:0000735) | 2.45155591 |
| 64 | Pheochromocytoma (HP:0002666) | 2.43437187 |
| 65 | Ventricular arrhythmia (HP:0004308) | 2.42284975 |
| 66 | Obstructive sleep apnea (HP:0002870) | 2.41360644 |
| 67 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.39447835 |
| 68 | Rapidly progressive (HP:0003678) | 2.38242396 |
| 69 | Broad-based gait (HP:0002136) | 2.37675381 |
| 70 | Asymmetric septal hypertrophy (HP:0001670) | 2.37057428 |
| 71 | Wormian bones (HP:0002645) | 2.35647358 |
| 72 | Ketoacidosis (HP:0001993) | 2.34585353 |
| 73 | Dysmetria (HP:0001310) | 2.32873898 |
| 74 | Bladder diverticulum (HP:0000015) | 2.32871931 |
| 75 | Aortic aneurysm (HP:0004942) | 2.32125710 |
| 76 | Heart block (HP:0012722) | 2.31326044 |
| 77 | Fetal akinesia sequence (HP:0001989) | 2.30691565 |
| 78 | Myoglobinuria (HP:0002913) | 2.30507810 |
| 79 | EEG with generalized epileptiform discharges (HP:0011198) | 2.30469845 |
| 80 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.30443692 |
| 81 | Hand muscle atrophy (HP:0009130) | 2.27977223 |
| 82 | Progressive cerebellar ataxia (HP:0002073) | 2.27768037 |
| 83 | Dysdiadochokinesis (HP:0002075) | 2.26812001 |
| 84 | Atrophic scars (HP:0001075) | 2.26522264 |
| 85 | Truncal ataxia (HP:0002078) | 2.26452243 |
| 86 | Bronchomalacia (HP:0002780) | 2.26392242 |
| 87 | Increased connective tissue (HP:0009025) | 2.25824887 |
| 88 | Right ventricular cardiomyopathy (HP:0011663) | 2.23675020 |
| 89 | Global brain atrophy (HP:0002283) | 2.22730367 |
| 90 | Increased variability in muscle fiber diameter (HP:0003557) | 2.22468698 |
| 91 | Stridor (HP:0010307) | 2.21373257 |
| 92 | Lower limb amyotrophy (HP:0007210) | 2.20056176 |
| 93 | Hypsarrhythmia (HP:0002521) | 2.19691420 |
| 94 | Difficulty climbing stairs (HP:0003551) | 2.19490527 |
| 95 | Ulnar bowing (HP:0003031) | 2.17783917 |
| 96 | Fragile skin (HP:0001030) | 2.17197455 |
| 97 | Type 1 muscle fiber predominance (HP:0003803) | 2.16859863 |
| 98 | Postural instability (HP:0002172) | 2.16723410 |
| 99 | Abnormal atrioventricular conduction (HP:0005150) | 2.16210746 |
| 100 | Neuroendocrine neoplasm (HP:0100634) | 2.15319771 |
| 101 | Ventricular tachycardia (HP:0004756) | 2.15229467 |
| 102 | Atrioventricular block (HP:0001678) | 2.14548913 |
| 103 | Resting tremor (HP:0002322) | 2.09804862 |
| 104 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.08624391 |
| 105 | Distal lower limb amyotrophy (HP:0008944) | 2.08317709 |
| 106 | J-shaped sella turcica (HP:0002680) | 2.07555923 |
| 107 | Decreased circulating renin level (HP:0003351) | 2.06932896 |
| 108 | Lymphangioma (HP:0100764) | 2.06639614 |
| 109 | Hyperacusis (HP:0010780) | 2.06076860 |
| 110 | Subaortic stenosis (HP:0001682) | 2.05902692 |
| 111 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.05902692 |
| 112 | Long toe (HP:0010511) | 2.05878812 |
| 113 | Dysmetric saccades (HP:0000641) | 2.05800871 |
| 114 | Skin nodule (HP:0200036) | 2.05489985 |
| 115 | Mucopolysacchariduria (HP:0008155) | 2.05234121 |
| 116 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.05234121 |
| 117 | Aneurysm (HP:0002617) | 2.02529912 |
| 118 | Neonatal short-limb short stature (HP:0008921) | 2.00426923 |
| 119 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.96778614 |
| 120 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.96778614 |
| 121 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.96778614 |
| 122 | Papilledema (HP:0001085) | 1.96578760 |
| 123 | Advanced eruption of teeth (HP:0006288) | 1.95760945 |
| 124 | Drooling (HP:0002307) | 1.95571897 |
| 125 | Excessive salivation (HP:0003781) | 1.95571897 |
| 126 | Atelectasis (HP:0100750) | 1.94692699 |
| 127 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.94550438 |
| 128 | Palpitations (HP:0001962) | 1.93901270 |
| 129 | Broad face (HP:0000283) | 1.93488963 |
| 130 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.93461603 |
| 131 | Hypoglycemic seizures (HP:0002173) | 1.91164613 |
| 132 | Mitral regurgitation (HP:0001653) | 1.90819130 |
| 133 | Back pain (HP:0003418) | 1.90505788 |
| 134 | Turricephaly (HP:0000262) | 1.90416965 |
| 135 | Spinal cord compression (HP:0002176) | 1.89857967 |
| 136 | Hemiparesis (HP:0001269) | 1.89420990 |
| 137 | Abnormality of the lower motor neuron (HP:0002366) | 1.88881019 |
| 138 | Soft skin (HP:0000977) | 1.88779047 |
| 139 | Xanthomatosis (HP:0000991) | 1.88194629 |
| 140 | Blue sclerae (HP:0000592) | 1.88096631 |
| 141 | Large for gestational age (HP:0001520) | 1.87907012 |
| 142 | Left ventricular hypertrophy (HP:0001712) | 1.86920527 |
| 143 | Type II lissencephaly (HP:0007260) | 1.86574919 |
| 144 | Bradykinesia (HP:0002067) | 1.85505136 |
| 145 | Hyperkalemia (HP:0002153) | 1.85479493 |
| 146 | Congenital glaucoma (HP:0001087) | 1.85379063 |
| 147 | Muscle fiber inclusion bodies (HP:0100299) | 1.84160911 |
| 148 | Athetosis (HP:0002305) | 1.83774076 |
| 149 | Hypokinesia (HP:0002375) | 1.82319539 |
| 150 | Diplopia (HP:0000651) | 1.82123527 |
| 151 | Abnormality of binocular vision (HP:0011514) | 1.82123527 |
| 152 | EMG: neuropathic changes (HP:0003445) | 1.81673881 |
| 153 | Deep venous thrombosis (HP:0002625) | 1.81349958 |
| 154 | Generalized amyotrophy (HP:0003700) | 1.80779016 |
| 155 | Impaired smooth pursuit (HP:0007772) | 1.80576076 |
| 156 | Insidious onset (HP:0003587) | 1.80362409 |
| 157 | Termporal pattern (HP:0011008) | 1.80362409 |
| 158 | Hyperextensible skin (HP:0000974) | 1.79353142 |
| 159 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.78202524 |
| 160 | Hyperparathyroidism (HP:0000843) | 1.77436788 |
| 161 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.76348642 |
| 162 | Aplasia of the phalanges of the hand (HP:0009802) | 1.76348642 |
| 163 | Aplasia involving bones of the extremities (HP:0009825) | 1.76348642 |
| 164 | Asymmetry of the thorax (HP:0001555) | 1.76120074 |
| 165 | Neonatal death (HP:0003811) | 1.75213786 |
| 166 | Hypoglycemic coma (HP:0001325) | 1.75003041 |
| 167 | Abnormality of the Achilles tendon (HP:0005109) | 1.74672305 |
| 168 | Acanthosis nigricans (HP:0000956) | 1.74250580 |
| 169 | Bradycardia (HP:0001662) | 1.73096219 |
| 170 | Hypoventilation (HP:0002791) | 1.72361401 |
| 171 | Follicular hyperkeratosis (HP:0007502) | 1.72272039 |
| 172 | Enlarged penis (HP:0000040) | 1.71885289 |
| 173 | Coronal craniosynostosis (HP:0004440) | 1.71723342 |
| 174 | Insulin resistance (HP:0000855) | 1.71055274 |
| 175 | Achilles tendon contracture (HP:0001771) | 1.70410390 |
| 176 | Mitral valve prolapse (HP:0001634) | 1.66390645 |
| 177 | Growth hormone excess (HP:0000845) | 1.65956581 |
| 178 | Bowel diverticulosis (HP:0005222) | 1.65744706 |
| 179 | Abnormality of carpal bone ossification (HP:0006257) | 1.65576631 |
| 180 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.62710400 |
| 181 | Natal tooth (HP:0000695) | 1.62610959 |
| 182 | Elbow flexion contracture (HP:0002987) | 1.61718337 |
| 183 | Coxa vara (HP:0002812) | 1.61707649 |
| 184 | Biconcave vertebral bodies (HP:0004586) | 1.61441527 |
| 185 | Abnormality of the acetabulum (HP:0003170) | 1.61398834 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.67681935 |
| 2 | NTRK3 | 4.48322932 |
| 3 | EPHA2 | 3.55419614 |
| 4 | RIPK4 | 3.44916683 |
| 5 | MAP3K9 | 3.11126711 |
| 6 | SIK1 | 2.98331535 |
| 7 | TESK1 | 2.76585671 |
| 8 | PRKD3 | 2.61351463 |
| 9 | EEF2K | 2.45860974 |
| 10 | KSR2 | 2.33393578 |
| 11 | MAPKAPK3 | 2.30621898 |
| 12 | NTRK1 | 2.12681435 |
| 13 | MAP3K4 | 2.12362350 |
| 14 | MINK1 | 2.05775402 |
| 15 | MET | 1.99683303 |
| 16 | ERN1 | 1.88774166 |
| 17 | ARAF | 1.85063443 |
| 18 | FGFR4 | 1.85033321 |
| 19 | ICK | 1.74608547 |
| 20 | LIMK1 | 1.71608309 |
| 21 | BMPR2 | 1.68459905 |
| 22 | PAK4 | 1.64006852 |
| 23 | PAK6 | 1.63406974 |
| 24 | PKN2 | 1.61831572 |
| 25 | PHKG2 | 1.61272785 |
| 26 | PHKG1 | 1.61272785 |
| 27 | SMG1 | 1.57149546 |
| 28 | MAP2K4 | 1.55345949 |
| 29 | DAPK2 | 1.51934303 |
| 30 | MAP2K7 | 1.50960201 |
| 31 | MAP3K13 | 1.49466070 |
| 32 | DMPK | 1.49196449 |
| 33 | MST1R | 1.44136571 |
| 34 | TIE1 | 1.43882751 |
| 35 | CAMKK1 | 1.43416803 |
| 36 | MAP3K2 | 1.42242571 |
| 37 | KSR1 | 1.38794289 |
| 38 | STK38 | 1.36225487 |
| 39 | INSRR | 1.34200166 |
| 40 | CDK5 | 1.33862189 |
| 41 | PINK1 | 1.33213793 |
| 42 | DAPK1 | 1.30532681 |
| 43 | PTK2B | 1.30438759 |
| 44 | TRPM7 | 1.29271914 |
| 45 | TTN | 1.28358292 |
| 46 | DDR2 | 1.26698962 |
| 47 | GRK5 | 1.25724826 |
| 48 | NME1 | 1.24097494 |
| 49 | LMTK2 | 1.23712912 |
| 50 | CAMK2A | 1.22563348 |
| 51 | EPHB2 | 1.21019702 |
| 52 | OBSCN | 1.18968958 |
| 53 | EPHB1 | 1.18633776 |
| 54 | CAMK2B | 1.17958309 |
| 55 | PAK3 | 1.14877003 |
| 56 | MAP3K1 | 1.12194070 |
| 57 | TRIB3 | 1.09835550 |
| 58 | MARK1 | 1.09176881 |
| 59 | RPS6KA2 | 1.07848697 |
| 60 | MUSK | 1.07122455 |
| 61 | PLK2 | 1.06157572 |
| 62 | MAPK15 | 1.04697707 |
| 63 | NTRK2 | 1.04307064 |
| 64 | MAP3K12 | 1.03832466 |
| 65 | MTOR | 1.02151794 |
| 66 | CAMK2D | 1.01992855 |
| 67 | PRKCG | 1.00424364 |
| 68 | PNCK | 0.94692111 |
| 69 | RAF1 | 0.94573989 |
| 70 | CDK12 | 0.91757182 |
| 71 | PRKCH | 0.91376305 |
| 72 | FER | 0.91185321 |
| 73 | MAP3K7 | 0.90482630 |
| 74 | FES | 0.89475690 |
| 75 | CAMKK2 | 0.88451009 |
| 76 | PDGFRA | 0.84171392 |
| 77 | SIK2 | 0.83560564 |
| 78 | PAK2 | 0.83469721 |
| 79 | FGFR2 | 0.83162064 |
| 80 | PRKG2 | 0.82579417 |
| 81 | CDC42BPA | 0.81892987 |
| 82 | RET | 0.81732991 |
| 83 | LATS2 | 0.81096144 |
| 84 | MAP2K1 | 0.81018799 |
| 85 | TYRO3 | 0.77749443 |
| 86 | ROCK1 | 0.76749153 |
| 87 | UHMK1 | 0.75588135 |
| 88 | PTK6 | 0.74783303 |
| 89 | IRAK3 | 0.74414618 |
| 90 | FGFR3 | 0.73735869 |
| 91 | SGK1 | 0.73598569 |
| 92 | MOS | 0.68252159 |
| 93 | SCYL2 | 0.68225812 |
| 94 | PDPK1 | 0.66535336 |
| 95 | PRKCE | 0.65967266 |
| 96 | GRK7 | 0.65099271 |
| 97 | PDK3 | 0.65094641 |
| 98 | PDK4 | 0.65094641 |
| 99 | WNK4 | 0.64812695 |
| 100 | CAMK1 | 0.64246332 |
| 101 | CAMK2G | 0.62265484 |
| 102 | PRPF4B | 0.62247724 |
| 103 | TAOK1 | 0.61950882 |
| 104 | PRKD2 | 0.60470518 |
| 105 | CDK8 | 0.59484135 |
| 106 | ERBB4 | 0.58867070 |
| 107 | MARK2 | 0.58540907 |
| 108 | PDK1 | 0.58326490 |
| 109 | SGK494 | 0.57551044 |
| 110 | SGK223 | 0.57551044 |
| 111 | CAMK1G | 0.56720594 |
| 112 | CDK14 | 0.56612107 |
| 113 | AKT2 | 0.55646187 |
| 114 | NEK1 | 0.54477426 |
| 115 | CDK18 | 0.54252779 |
| 116 | TNIK | 0.54183395 |
| 117 | STK11 | 0.53843137 |
| 118 | BRAF | 0.53405020 |
| 119 | CDK15 | 0.53235409 |
| 120 | DAPK3 | 0.53046939 |
| 121 | PRKAA2 | 0.52412012 |
| 122 | ABL2 | 0.52287697 |
| 123 | PRKAA1 | 0.52045481 |
| 124 | SGK3 | 0.51613670 |
| 125 | WNK1 | 0.51453256 |
| 126 | MYLK | 0.51267077 |
| 127 | RIPK1 | 0.51239735 |
| 128 | ILK | 0.50984928 |
| 129 | PRKD1 | 0.50291178 |
| 130 | SGK2 | 0.50070723 |
| 131 | PDGFRB | 0.49840578 |
| 132 | HIPK2 | 0.49636694 |
| 133 | TGFBR2 | 0.48622220 |
| 134 | RPS6KA3 | 0.47706352 |
| 135 | CASK | 0.46122716 |
| 136 | RPS6KB2 | 0.45517248 |
| 137 | LATS1 | 0.44204117 |
| 138 | CDK9 | 0.42680627 |
| 139 | MAP3K3 | 0.42637486 |
| 140 | CDK11A | 0.42587672 |
| 141 | MAPK10 | 0.42203765 |
| 142 | BRSK1 | 0.41611705 |
| 143 | PRKACA | 0.41428650 |
| 144 | FGR | 0.41255420 |
| 145 | PTK2 | 0.40359576 |
| 146 | CAMK1D | 0.39735349 |
| 147 | MAP2K6 | 0.39378390 |
| 148 | NEK9 | 0.39338964 |
| 149 | AKT3 | 0.39301116 |
| 150 | GSK3A | 0.38399126 |
| 151 | ROCK2 | 0.37943127 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.93347092 |
| 2 | Long-term potentiation_Homo sapiens_hsa04720 | 2.84299560 |
| 3 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.57611147 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.50682519 |
| 5 | Insulin secretion_Homo sapiens_hsa04911 | 2.34180118 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.26980087 |
| 7 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.25962451 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.18767285 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.17731766 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.15882432 |
| 11 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.11968630 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 2.06898872 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.06566018 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.00818285 |
| 15 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.89886734 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.89843354 |
| 17 | Renin secretion_Homo sapiens_hsa04924 | 1.86833174 |
| 18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.85399080 |
| 19 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.85059403 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.83439443 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.82237846 |
| 22 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.79869656 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 1.79165681 |
| 24 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.71198701 |
| 25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.70851800 |
| 26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.68932334 |
| 27 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.68499211 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.64641352 |
| 29 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.61400694 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.61078679 |
| 31 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.49407505 |
| 32 | Long-term depression_Homo sapiens_hsa04730 | 1.49393531 |
| 33 | Focal adhesion_Homo sapiens_hsa04510 | 1.44573735 |
| 34 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.40753280 |
| 35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.37925671 |
| 36 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.35769866 |
| 37 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.34850754 |
| 38 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.33497761 |
| 39 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.29540218 |
| 40 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.29477301 |
| 41 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.29295923 |
| 42 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.27360695 |
| 43 | Gap junction_Homo sapiens_hsa04540 | 1.26241977 |
| 44 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.25285134 |
| 45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.20430954 |
| 46 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.15323428 |
| 47 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.13042561 |
| 48 | Alzheimers disease_Homo sapiens_hsa05010 | 1.11253270 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.10497829 |
| 50 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.10438614 |
| 51 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.10436136 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.10095169 |
| 53 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.10027500 |
| 54 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.09896039 |
| 55 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.09796356 |
| 56 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.07550450 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.06844015 |
| 58 | Glioma_Homo sapiens_hsa05214 | 1.05199584 |
| 59 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.05114477 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.04196756 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.03966379 |
| 62 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.03047296 |
| 63 | Galactose metabolism_Homo sapiens_hsa00052 | 1.02796888 |
| 64 | Melanogenesis_Homo sapiens_hsa04916 | 1.01106816 |
| 65 | Adherens junction_Homo sapiens_hsa04520 | 1.00868155 |
| 66 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.00399637 |
| 67 | Histidine metabolism_Homo sapiens_hsa00340 | 0.96504334 |
| 68 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.96214468 |
| 69 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.95378616 |
| 70 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.95132641 |
| 71 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.95099616 |
| 72 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.92877917 |
| 73 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.92631976 |
| 74 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.91017902 |
| 75 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.89088074 |
| 76 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85476175 |
| 77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.85405529 |
| 78 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.84711276 |
| 79 | Lysosome_Homo sapiens_hsa04142 | 0.84359023 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.82473517 |
| 81 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.82376300 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.82004758 |
| 83 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.81694837 |
| 84 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.81303176 |
| 85 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.81005735 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.80810102 |
| 87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.80049255 |
| 88 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.78257830 |
| 89 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78184978 |
| 90 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.76321271 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76151487 |
| 92 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.75559672 |
| 93 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.75060333 |
| 94 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.72186472 |
| 95 | Carbon metabolism_Homo sapiens_hsa01200 | 0.71620472 |
| 96 | Parkinsons disease_Homo sapiens_hsa05012 | 0.71260568 |
| 97 | Axon guidance_Homo sapiens_hsa04360 | 0.70449772 |
| 98 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.70409057 |
| 99 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69881249 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | 0.69624307 |
| 101 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.68416784 |
| 102 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.67229692 |
| 103 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.66816217 |
| 104 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65328130 |
| 105 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64582002 |
| 106 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64003158 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.63207342 |
| 108 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63148811 |
| 109 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62873346 |
| 110 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.62730426 |
| 111 | Phototransduction_Homo sapiens_hsa04744 | 0.61673253 |
| 112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.61239238 |
| 113 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.60956564 |
| 114 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60562075 |
| 115 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.60092807 |
| 116 | Circadian rhythm_Homo sapiens_hsa04710 | 0.57891518 |
| 117 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57218582 |
| 118 | Sulfur relay system_Homo sapiens_hsa04122 | 0.57212994 |
| 119 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.55552598 |
| 120 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.53712917 |
| 121 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.53634084 |
| 122 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.53371716 |
| 123 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.53135493 |
| 124 | Thyroid cancer_Homo sapiens_hsa05216 | 0.53111234 |
| 125 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.52223229 |
| 126 | Prion diseases_Homo sapiens_hsa05020 | 0.51352582 |
| 127 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49428685 |
| 128 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47936371 |
| 129 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46489768 |
| 130 | Bile secretion_Homo sapiens_hsa04976 | 0.45516212 |
| 131 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45258952 |
| 132 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.43910875 |
| 133 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43429427 |
| 134 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.42945963 |
| 135 | Huntingtons disease_Homo sapiens_hsa05016 | 0.41963194 |
| 136 | Insulin resistance_Homo sapiens_hsa04931 | 0.41874326 |
| 137 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.40093951 |
| 138 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.37597537 |
| 139 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35824105 |
| 140 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.34446020 |
| 141 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33178006 |
| 142 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.31695696 |
| 143 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.31086754 |
| 144 | Mineral absorption_Homo sapiens_hsa04978 | 0.28962554 |
| 145 | Endocytosis_Homo sapiens_hsa04144 | 0.28056220 |
| 146 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.27875534 |
| 147 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.27824635 |
| 148 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.27143503 |
| 149 | Tight junction_Homo sapiens_hsa04530 | 0.26999094 |
| 150 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26626059 |
| 151 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.25832215 |

